Fidelity
VC Fund
Boston, United States
Fidelity is a privately owned investment management firm that serves a wide range of clients. It offers services including IRAs, rollovers, annuities, discount brokerage, retirement planning, estate planning, wealth management, securities execution and clearance, and life insurance. They serve individual investors, businesses, financial advisors,and institutions. The firm manages equity, fixed-income, and balanced mutual funds and invests in public equity and fixed-income markets. It also conducts in-house research to inform its investment decisions.
- Total investments:
- 255
- Last investment:
- Lead investor:
- 29%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Fidelity invests in
Stages Fidelity invests in
Countries Fidelity invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 10 contacts → | |||
Round size
- Series B
- $36M–$265M
- Series C
- $42M–$276M
- Post-IPO Equity
- $130M–$854M
Investment Focus
Industry
- Biotechnology 84 (33%)
- Health Care 68 (27%)
- Medical 40 (16%)
- Therapeutics 33 (13%)
- Software 24 (9%)
Stage
- Post-IPO Equity 54 (21%)
- Series B 45 (18%)
- Series C 41 (16%)
- Series D 22 (9%)
- Venture - Series Unknown 14 (5%)
Country
- United States 180 (71%)
- Canada 5 (2%)
- India 4 (2%)
- United Kingdom 4 (2%)
- China 2 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Abigail Johnson
Chairman, CEO, and president
|
Chairman, CEO, and president | Total investments: 0 | Find email | |
Eric Wells
Senior Vice President - Technology Compliance
|
Senior Vice President - Technology Compliance | Total investments: 0 | Find email | |
Jennifer Samalis
Senior Vice President
|
Senior Vice President | Total investments: 0 | Find email | |
Lawrence Conover
Vice President, Corporate Actions
|
Vice President, Corporate Actions | Total investments: 0 | Find email | |
Leilani Farol
Head of Office of the CISO
|
Head of Office of the CISO | Total investments: 0 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions. The company was founded in 2021 and is headquartered in Stamford, CT. | $200M / Series A / Sep 03, 2025 | ||
| Galvanize Therapeutics is an energy-based medical device technology that provides therapeutic products and services to deliver healthcare solutions. The company aims to become the global leader in delivering medical technology innovations that drive biological processes to treat a range of diseases, starting with treating chronic bronchitissymptoms, cardiac arrhythmias, and solid tumors.It was formed by Apple Tree Partners in 2022. | $100M / Series C / Sep 03, 2025 | ||
| Anthropic develops artificial intelligence tools and research initiatives focused on creating AI systems and models for business and research use. The company produces the Claude family of AI products, including conversational and coding assistants, integrations with productivity applications, and developer APIs that organizations can deploy for automation, information retrieval, and task workflows. It also engages in systematic research and analysis of AI behavior, safety methods, and policy issues to inform product design and external stakeholders. Beyond product development, Anthropic generates documented insights and collaborates with academic, civil society, and industry groups to explore implications of AI on economic and societal systems. These efforts aim to connect foundational research with practical AI applications in enterprise environments. | $13B / Series F / Sep 02, 2025 | ||
| Wugen is developing off-the-shelf cellular therapies for cancer. Our NK cell therapy products originate from healthy donors and are further manipulated in order to enhance their function to eliminate cancer cells. Our NK cell and CAR-T immuno-oncology therapies address the needs of patients with solid tumors, acute myeloid leukemia (AML) and T-cellmalignancies. | $115M / Series C / Aug 27, 2025 | ||
| Apollo Hospitals is widely recognized as the pioneer of private healthcare in India, and was the country’s first corporate hospital. The Apollo Hospitals Group, which started as a 150-bed hospital and today, operates 9200 beds across 64 hospitals. A forerunner in integrated healthcare, Apollo has a robust presence across the healthcare spectrum.The Group has emerged as the foremost integrated healthcare provider in Asia, with mature group companies that specialize in insurance, pharmacy, consultancy, clinics and many such key touch points of the ecosystem. The Apollo Group has touched the lives of over 45 million patients, from 121 countries. | $170.5M / Post-IPO Secondary / Aug 22, 2025 | ||
| Canva is a graphic design software solutions provider that helps users to design presentations, social media graphics, and more with various layouts, images, photo filters, icons and shapes, and fonts. The platform combines a drag-and-drop design tool with a stock library of photographs, illustrations, and imagery.It was founded in 2012 andheadquartered in Sydney, New South Wales. | Secondary Market / Aug 20, 2025 | ||
| Shoulder Innovations is a medical device company that has developed inset glenoid fixation technology, creating the most robust and stable glenoid platform in the industry. The company's Total Shoulder Replacement System addresses the most significant issue in shoulder arthroplasty: unreliable fixation of the glenoid implant. It also leveragesthis technology to create simple surgical instrumentation, which reduces operative time and cost.Shoulder Innovations designs and commercializes innovative products that demonstrate the potential for improved patient care and reduced overall cost to the healthcare system. Published results show Shoulder Innovations’ solution provides greater post-surgical implant stability, addressing the leading cause of revision surgery. | $115M / Convertible Note / Jul 21, 2025 | ||
| Kardium is a medical solutions company that develops a globe pulsed field system for the diagnosis and treatment of atrial fibrillation. Its flagship Globe Pulsed Field System integrates high-definition mapping, pulmonary vein isolation, and atrial ablation into a single spherical catheter featuring 122 electrodes. | $250.2M / Private Equity / Jul 02, 2025 | ||
| Bruce Markets is designed to provide seamless digital investor experiences. | Venture - Series Unknown / Jun 25, 2025 | ||
| Applied Intuition is the vehicle intelligence company that accelerates the global adoption of safe, AI-driven machines. Founded in 2017 and now valued at $15 billion following its recent Series F funding round, Applied Intuition delivers the Vehicle OS, Self-Driving System, and toolchain to help customers build intelligent vehicles and shorten timeto market. 18 of the top 20 global automakers and major programs across the Department of Defense trust Applied Intuition's solutions to deliver vehicle intelligence. Applied Intuition services the automotive, defense, trucking, construction, mining, and agriculture industries and is headquartered in Mountain View, CA, with offices in Washington, D.C., San Diego, CA, Ft. Walton Beach, FL, Ann Arbor, MI, London, Stuttgart, Munich, Stockholm, Bangalore, Seoul, and Tokyo. | $600M / Series F / Jun 17, 2025 | ||
| See all 255 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Fidelity invest in?
Fidelity invests primarily in Biotechnology, Health Care and Medical startups, most often at Post-IPO Equity and Series B stage. Most of the 255 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Fidelity invest in?
Fidelity typically joins rounds of $36M–$265M at Series B, $42M–$276M at Series C and $130M–$854M at Post-IPO Equity. These are whole funding-round sizes, not Fidelity's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Fidelity took part in.
How do I contact Fidelity?
Public channels for Fidelity include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Fidelity?
The team at Fidelity includes Abigail Johnson (Chairman, CEO, and president), Eric Wells (Senior Vice President - Technology Compliance) and Jennifer Samalis (Senior Vice President), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
